Search Results 781-790 of 17710 for prednisone

  1. A Study of Subcutaneous Nivolumab + Relatlimab FDC in Previously Untreated Metastatic or Unresectable Melanoma - Mayo Clinic

    In addition, participants must have been either off corticosteroids, or on a stable or decreasing dose of ≤ 10 mg daily prednisone (or equivalent) for at least ...

  2. Analyzing Stem Cell Functionality in Obese Patients - Mayo Clinic

    Therapeutic doses of immunosuppressive drugs (including calcineurin inhibitors and prednisone (>10 mg/day);; Senolytic supplements;; Subjects on therapeutic ...

  3. A Study of Idasanutlin in Combination With Obinutuzumab in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and in Combination With Rituximab in R/R Diffuse Large B-Cell Lymphoma (DLBCL) Participants - Mayo Clinic

    ... 1 of Cycle 1; Current use of systemic corticosteroids greater than (>) 20 mg prednisone per day (or equivalent), or prior anti-cancer therapy to include ...

  4. A Phase 2/3 Study of Andecaliximab in Participants with Fibrodysplasia Ossificans Progressiva (FOP) in Two Parts with an Open-Label Extension (OLE) (ANDECAL) - Mayo Clinic

    Systemic corticosteroids with a prednisone equivalent of >10mg/day within 1 week of Study Day 1. If the participant requires chronic use of >10mg/day ...

  5. A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients With Advanced Sarcomas - Mayo Clinic

    ... prednisone) in the morning and 10 mg hydrocortisone (or 2.5 mg prednisone) in the evening. Patients with the risk factors for bowel obstruction or bowel ...

  6. Why choose Mayo Clinic for surgical care

    Dr. Reisenauer: We implement a multidisciplinary team which involves people with research expertise so that patients are exposed to clinical trials. Dr.

  7. A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Ulcerative Colitis - Mayo Clinic

    Steroids (i.e., prednisone/budesonide/budesonide MMX); Immunosuppressant (i.e., methotrexate/azathioprine/6-mercaptopurine); Other immunosuppressant (i.e. ...

  8. A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies (ERADIC8) - Mayo Clinic

    Receiving continuous corticosteroids at prednisone-equivalent dose of >10 mg/day. Chronic systemic corticosteroid therapy for physiologic replacement (≤10 ...

  9. Paraneoplastic syndromes of the nervous system - Symptoms and causes - Mayo Clinic

    Prednisone oral. Facts & Comparisons eAnswers. https://fco.factsandcomparisons.com. Accessed Jan. 10, 2024. Hehir MK, et al. Diagnosis and management of ...

  10. Study of Oraxol and Pembrolizumab in Subjects with Advanced Solid Tumors - Mayo Clinic

    of prednisone or its equivalent. - Vaccinated with live, attenuated vaccines within 28 days of the first dose of the study drug - Active or prior documented ...